Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for ITCI stock have an median target of 132, with a low estimate of 89 and a high estimate of 132. The median target predicts an increase of 0.10% from the current stock price of 131.87.
Target | Low | Average | Median | High |
---|---|---|---|---|
Price | 89 | 120.57 | 132 | 132 |
Change | -32.51% | -8.57% | 0.10% | 0.10% |
Latest Analyst Insight Report
Cantor Fitzgerald maintained a Neutral rating on I... Unlock content with Pro Subscription
Updated Apr 02, 2025
Rating | Sep 24 | Oct 24 | Nov 24 | Jan 25 | Feb 25 | Apr 25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 3 | 4 | 1 | 1 | 0 | 0 |
Hold | 0 | 0 | 0 | 4 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 4 | 1 | 5 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
925.56M
from 680.85M
Increased by 35.9%
Revenue Next Year
1.43B
from 925.56M
Increased by 54.7%
EPS This Year
0.8
from -0.72
Increased by -11.1%
EPS Next Year
4.31
from 0.8
Increased by 438.7%